Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes.
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Unstimulated peripheral blood mononuclear cells (PBMCs) from corticosteroid-resistant (CR) but not corticosteroid-sensitive (CS) asthmatics demonstrate increased activating peptide-1 (AP-1)- and decreased glucocorticoid receptor (GR)-DNA binding. We test whether these abnormalities are associated with excessive generation of c-fos, the inducible component of AP-1. The c-fos transcription rate, mRNA and protein levels, and GR-DNA binding were quantitated in PBMCs, T cells, and monocytes from CS, CR, and nonasthmatic subjects. There was a 1.7-, 4.2-, and 2.3-fold greater increase in the baseline c-fos transcription rate, mRNA expression, and protein levels, respectively, in PBMCs derived from CR compared with CS patients. At optimal stimulation with PMA, there was a 5.7-, 3.4-, and 2-fold greater increase in the c-fos transcription rate, mRNA accumulation, and protein levels, respectively, in CR compared with CS PBMCs. These abnormalities were detected in both the T cell and monocyte subpopulations. PMA stimulation converted PBMCs from a CS to a CR phenotype and was associated with direct interaction between c-Fos and the GR. Pretreatment of PBMCs from CR patients with c-fos antisense oligonucleotides enhanced GR-DNA binding activity in CR PBMCs stimulated with dexamethasone. We suggest that increased c-fos synthesis provides a major mechanism for the increased AP-1- and decreased GR- DNA binding seen in CR asthma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yang-Yen, H.-F., Chambard, J.-C., Sun, Y.-L., Smeal, T., Schmidt, T. J., Drouin, J., & Karin, M. (1990) · Cell · doi:10.1016/0092-8674(90)90396-v · Cited by 1,553 · cited 1×
“The present findings provide a novel mechanism for corticosteroid resistance since an excess of AP-1 would be expected to overcome the antiinflammatory effects of a limited number of available GRs in any cell (31, 32).”
BackgroundRegulation of transcription by MAP kinase cascades
Treisman, R. (1996) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(96)80067-6 · Cited by 1,296
Cited by
Asthma: defining of the persistent adult phenotypes
Wenzel, S. E. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69290-8 · Cited by 1,043
Glucocorticoid resistance in inflammatory diseases
Barnes, P. J., & Adcock, I. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60326-3 · Cited by 983
Self-citationDe Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898
“Enhanced JNK activation in steroid-resistant patients may contribute to steroid unresponsiveness by various mechanisms, either directly by inhibiting GR activity (by blocking its phosphorylation) or indirectly by increasing AP-1 activity, which transrepresses the GC effects (717, 718).”
BackgroundCorticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease
Barnes, P. J. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.12.1564 · Cited by 694
Self-citationGene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells
Galon, J., Franchimont, D., Hiroi, N., Frey, G., Boettner, A., Ehrhart-Bornstein, M., O’shea, J. J., Chrousos, G. P., & Bornstein, S. R. (2002) · The FASEB Journal · doi:10.1096/fj.01-0245com · Cited by 606
Distinguishing severe asthma phenotypes
Miranda, C., Busacker, A., Balzar, S., Trudeau, J., & Wenzel, S. E. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.10.041 · Cited by 586
Glucocorticosteroids: current and future directions
Barnes, P. J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01199.x · Cited by 533
Self-citationUpdate on glucocorticoid action and resistance
Nelson, H. S., Leung, D. Y. M., & Bloom, J. W. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.97 · Cited by 413
Update on glucocorticoid action and resistance
Ito, K., Chung, K. F., & Adcock, I. M. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.01.032 · Cited by 397
Self-citationCross‐talk between pro‐inflammatory transcription factors and glucocorticoids
Adcock, I. M., & Caramori, G. (2001) · Immunology & Cell Biology · doi:10.1046/j.1440-1711.2001.01025.x · Cited by 330
Self-citationMechanisms and resistance in glucocorticoid control of inflammation
Barnes, P. J. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.02.018 · Cited by 317
Heterogeneity of therapeutic responses in asthma
Drazen, J. M., Silverman, E. K., & Lee, T. H. (2000) · British Medical Bulletin · doi:10.1258/0007142001903535 · Cited by 318
Self-citationWenzel, S. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200409-1181pp · Cited by 309
Beck, I. M. E., Vanden Berghe, W., Vermeulen, L., Yamamoto, K. R., Haegeman, G., & De Bosscher, K. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0013 · Cited by 298
Effects of glucocorticoids on gene transcription
Hayashi, R., Wada, H., Ito, K., & Adcock, I. M. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.011 · Cited by 277
Self-citationSousa, A. R., Lane, S. J., Cidlowski, J. A., Staynov, D. Z., & Lee, T. H. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.106486 · Cited by 274
Self-citationMatthews, J. G., Ito, K., Barnes, P. J., & Adcock, I. M. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.03.018 · Cited by 205
Self-citationOnda, K., Nagashima, M., Kawakubo, Y., Inoue, S., Hirano, T., & Oka, K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.032 · Cited by 28
Takahashi, E., Onda, K., Hirano, T., Oka, K., Maruoka, N., Tsuyuguchi, M., Matsumura, Y., Niitsuma, T., & Hayashi, T. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00083-8 · Cited by 20
Metadata
- Authors
- Lane, S. J., Adcock, I. M., Richards, D., Hawrylowicz, C., Barnes, P. J., & Lee, T. H.
- Venue
- Journal of Clinical Investigation
- Published
- 1998-12-15
- Volume
- 102
- Issue
- 12
- Pages
- 2156-2164
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1968671826
- Cited by
- 147
- References
- 2
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.